Life science News and Research

RSS

North Carolina Biotechnology Center establishes Research Triangle Park headquarters

To continue the state life science industry’s record-setting growth rate, the North Carolina Biotechnology Center, with the help of statewide partners, is building an addition to its Research Triangle Park headquarters.

10 Sep 2009

arGEN-X BV announces first closing of its Series A equity financing round

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.

10 Sep 2009

ARUP Laboratories' scientist receives grant to research HIV therapies

ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced that ARUP's Tanya Sandrock, PhD, Research & Development scientist, received a prestigious National Institutes of Health (NIH) grant to research additional HIV therapies.

9 Sep 2009

North Carolina Biotechnology Center awarded a transformational grant by the Biogen Idec Foundation

The Biogen Idec Foundation today announced it has awarded a $1 million Transformational Grant in Science Education to the North Carolina Biotechnology Center to support the expansion of the Center’s educational training facility for K-12 science teachers. The grant is part of the Biogen Idec Foundation’s new Transformational Grants in Science Education initiative. The Foundation has awarded approximately $1.5 million in transformational grants since the program was initiated in 2008.

9 Sep 2009

Merck KGaA acquires Suzhou Taizhu Technology Development for € 28 million

Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.

9 Sep 2009

Dilafor Phase II clinical trial completes

Karolinska Development (publ) today announced that one of its portfolio companies, Dilafor AB, has concluded an extensive clinical study of its candidate drug, tafoxiparin, a new drug substance for the prevention of protracted labor during childbirth.

4 Sep 2009

CELDA used for assessing the cerebrospinal fluid granted CE marking

LinkMed’s portfolio company Likvor has been granted CE marking for its instrument for better and safer identification and diagnosis of Normal Pressure Hydrocephalus (NPH).

4 Sep 2009

New Technology Showcase highlighting life science technologies to be featured

LifeScience Alley announced today that eight life science organizations from around the United States and Canada will be exhibiting cutting-edge technologies at the association’s Annual Conference on Dec. 9 as part of the New Technology Showcase.

3 Sep 2009

Agilent Technologies announces split of its Life Science and Chemical Analysis Group

Agilent Technologies Inc. (NYSE:A) has announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences. The change in structure reflects the growth opportunities of each business and supports Agilent’s continued evolution as a leading bio-analytical company.

3 Sep 2009

Analytical Technologies division of MDS to be acquired by Danaher

Danaher Corporation (NYSE: DHR) today announced that it has signed a definitive agreement with MDS Inc. (TSX: MDS; NYSE: MDZ) to acquire the Analytical Technologies division of MDS, which includes a 50% ownership position in Applied Biosystems/MDS Sciex joint venture ("AB SCIEX"), a mass spectrometry business, and a 100% ownership position in the former Molecular Devices Corporation, a bioresearch and analytical instrumentation company.

From Danaher 2 Sep 2009

Danaher to acquire mass spectrometry business from Life Technologies Corporation

Life Technologies Corporation (NASDAQ:LIFE) today announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation (NYSE:DHR) for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint venture partner in the mass spectrometry business, MDS Analytical Technologies, a division of MDS Inc. (NYSE:MDZ). The transaction is expected to close in the fourth quarter of 2009.

From Danaher 2 Sep 2009

Research is active and diverse in U.S. academic medical centers

A survey indicates that research is active and diverse at U.S. academic medical centers and that a substantial proportion of faculty conduct research and publish without sponsorship, according to a study in the September 2 issue of JAMA.

2 Sep 2009

BioClinica offers streamlined electronic transport solutions with the acquisition of CardioNow

BioClinica, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced that it has acquired the CardioNow unit of Agfa HealthCare.

From Clario 1 Sep 2009

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, helped raise approximately $1.1 million during the Napa Valley Tour de Cure, which took place on May 3 to benefit the American Diabetes Association.

1 Sep 2009

MabCure featured in the August edition of Biotechnology Focus magazine

MabCure, Inc. (“MabCure”), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, has been featured in the August edition of Biotechnology Focus, Canada's oldest and most successful magazine serving the Canadian life science industry.

31 Aug 2009

Veeva Systems bags order from three new customers

With the macro U.S. economy starting to show signs of recovery, the life sciences sector is reaching for new remedies to cure its financial ills.

31 Aug 2009

NAT gains importance as traditional testing methods become inadequate

An expanding population of bacterial strains that are drug resistant, including methicillin-resistant Staphylococcus aureus (MRSA), will be the most important justification for nucleic acid-based tests (NAT).

28 Aug 2009

Fluidigm manufactures more than 250 million microscopic NanoFlex valves at its Singapore biochip factory

Fluidigm today announced that its Singapore biochip factory has manufactured and shipped more than 250 million microscopic NanoFlex™ valves. The 250 million valves built into Fluidigm’s integrated fluidic circuits (IFCs) would be equivalent to the number of valves required for all the conventional plumbing – both residential and commercial – in a metropolitan region the size of the San Francisco Bay Area.

27 Aug 2009

IVD labeled staining reagents for manual and automated staining platforms from DBS

Diagnostic Biosystems (DBS), a specialty immunohistochemistry (IHC) reagent company, announces the availability of products for clinical use in the US.

27 Aug 2009

Lack of imagination and aversion to commercial risk are the biggest threats to Australia’s medical innovation

Australia could be a world leader in medical innovation but commercial risk aversion and parochialism are holding the industry back, a leading venture capitalist will argue at a public lecture and debate at the University of New South Wales next week (Monday, 31 August).

26 Aug 2009

Life science News and Research

North Carolina Biotechnology Center establishes Research Triangle Park headquarters

arGEN-X BV announces first closing of its Series A equity financing round

ARUP Laboratories' scientist receives grant to research HIV therapies

North Carolina Biotechnology Center awarded a transformational grant by the Biogen Idec Foundation

Merck KGaA acquires Suzhou Taizhu Technology Development for € 28 million

Dilafor Phase II clinical trial completes

CELDA used for assessing the cerebrospinal fluid granted CE marking

New Technology Showcase highlighting life science technologies to be featured

Agilent Technologies announces split of its Life Science and Chemical Analysis Group

Analytical Technologies division of MDS to be acquired by Danaher

Danaher to acquire mass spectrometry business from Life Technologies Corporation

Research is active and diverse in U.S. academic medical centers

BioClinica offers streamlined electronic transport solutions with the acquisition of CardioNow

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

MabCure featured in the August edition of Biotechnology Focus magazine

Veeva Systems bags order from three new customers

NAT gains importance as traditional testing methods become inadequate

Fluidigm manufactures more than 250 million microscopic NanoFlex valves at its Singapore biochip factory

IVD labeled staining reagents for manual and automated staining platforms from DBS

Lack of imagination and aversion to commercial risk are the biggest threats to Australia’s medical innovation

An introduction to high-content analysis in modern life science research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News